Lucid Diagnostics Inc. (LUCD)
0.82
-0.01 (-0.71%)
At close: Jan 15, 2025, 12:28 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -52.67M | -56.17M | -28.08M | -8.28M | -4.42M | -1.13M |
| Depreciation & Amortization | 2.50M | 1.94M | 4.00K | n/a | n/a | n/a |
| Stock-Based Compensation | 6.82M | 14.99M | 9.60M | 65.00K | 173.94K | 79.85K |
| Other Working Capital | 5.61M | 9.17M | 1.67M | 1.44M | 1.58M | 222.83K |
| Other Non-Cash Items | 4.85M | 653.00K | 10.47M | -1.08M | -127.91K | -205.06K |
| Deferred Income Tax | n/a | n/a | -10.47M | n/a | n/a | n/a |
| Change in Working Capital | 5.67M | 8.91M | 807.00K | 2.59M | 1.89M | 720.05K |
| Operating Cash Flow | -32.82M | -29.68M | -17.67M | -5.63M | -2.36M | -113.70K |
| Capital Expenditures | -221.00K | -908.00K | -862.00K | n/a | n/a | n/a |
| Acquisitions | n/a | -3.20M | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | -3.20M | -862.00M | n/a | n/a | n/a |
| Investing Cash Flow | -221.00K | -4.11M | -862.00K | n/a | n/a | n/a |
| Debt Repayment | 10.00M | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 19.18M | 804.00K | 2.08M | 5.58M | 2.50M | 131.50K |
| Financial Cash Flow | 29.46M | 2.61M | 72.08M | 5.58M | 2.50M | 131.50K |
| Net Cash Flow | -3.58M | -31.18M | 53.55M | -45.15K | 138.60K | 17.80K |
| Free Cash Flow | -33.04M | -30.59M | -18.53M | -5.63M | -2.36M | -113.70K |